430 related articles for article (PubMed ID: 15553071)
21. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.
Petrovic LM
Liver Int; 2007 Jun; 27(5):598-606. PubMed ID: 17498243
[TBL] [Abstract][Full Text] [Related]
22. [Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection].
Mauss S
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():60-2. PubMed ID: 10863316
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation in HIV-positive patients.
Eisenbach C; Merle U; Stremmel W; Encke J
Clin Transplant; 2009 Dec; 23 Suppl 21():68-74. PubMed ID: 19930319
[TBL] [Abstract][Full Text] [Related]
24. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
Duclos-Vallée JC; Vittecoq D; Teicher E; Feray C; Roque-Afonso AM; Lombès A; Jardel C; Gigou M; Dussaix E; Sebagh M; Guettier C; Azoulay D; Adam R; Ichaï P; Saliba F; Roche B; Castaing D; Bismuth H; Samuel D
J Hepatol; 2005 Mar; 42(3):341-9. PubMed ID: 15710216
[TBL] [Abstract][Full Text] [Related]
26. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
27. Hyperlipidemia in HIV-infected patients: the protective effect of hepatitis C virus co-infection.
Collazos J; Mayo J; Ibarra S; Cazallas J
AIDS; 2003 Apr; 17(6):927-9. PubMed ID: 12660545
[No Abstract] [Full Text] [Related]
28. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis C in HIV infected patients].
Bukh J; Nielsen JO
Ugeskr Laeger; 2006 Oct; 168(42):3599. PubMed ID: 17069719
[No Abstract] [Full Text] [Related]
30. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
[TBL] [Abstract][Full Text] [Related]
31. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Vogel M; Rockstroh JK
Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
[TBL] [Abstract][Full Text] [Related]
32. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
33. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
34. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356
[TBL] [Abstract][Full Text] [Related]
35. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
36. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
Carosi G; Puoti M; Antonucci G; De Luca A; Maserati R; Torti C; Bonfanti P; Bonora S; Bruno R; Gaeta GB; Antinori A; Monforte Ad; Orani A; Sagnelli E; Cargnel A; Cauda R; Mazzotta F; Pastore G; Suter F; Vullo V; ;
AIDS Rev; 2005; 7(3):161-7. PubMed ID: 16302464
[TBL] [Abstract][Full Text] [Related]
37. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
38. [Management of HCV-HIV patients].
Pol S; Cacoub P; Pialoux G; Benhamou Y; Halfon P; Rosenthal E; Perronne C
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S7-12. PubMed ID: 17965629
[TBL] [Abstract][Full Text] [Related]
39. HIV-hepatitis C virus co-infection is associated with decreased plasmatic IL-7 levels.
Soriano-Sarabia N; Vallejo A; Molina-Pinelo S; Genebat M; del Mar Rodríguez M; Sánchez-Quijano A; Martínez-Moya M; Vivancos J; Leal M
AIDS; 2007 Jan; 21(2):253-5. PubMed ID: 17197823
[TBL] [Abstract][Full Text] [Related]
40. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
Torti C; Lapadula G; Uccelli MC; Quiros-Roldan E; Regazzi M; Ladisa N; Micheli V; Orani A; Patroni A; Caputo SL; Tirelli V; Di Giambenedetto S; Cologni G; Costarelli S; Gargiulo F; Manca N; Carosi G;
Int J Antimicrob Agents; 2007 Feb; 29(2):185-90. PubMed ID: 17011754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
